See the DrugPatentWatch profile for Triesence
What is Triesence, and what does an intravitreal injection do?
Triesence (triamcinolone acetonide) is a corticosteroid given by intravitreal injection, meaning it is injected into the eye’s vitreous cavity. It reduces inflammation and swelling inside the eye, which can help in conditions where fluid and inflammatory activity threaten vision.
What conditions is Triesence used to treat (intravitreal)?
Triesence intravitreal injection is used for eye diseases where reducing intraocular inflammation and macular swelling can improve outcomes, such as:
- Diabetic macular edema
- Macular edema related to uveitis (inflammation inside the eye)
- Macular edema after retinal vein occlusion
(Use is determined by the prescribing clinician based on the specific diagnosis and eye findings.)
How is a Triesence injection given?
An ophthalmologist administers Triesence inside the eye during an office procedure. Typical steps include sterile preparation, local anesthesia, and then injection into the vitreous cavity using a fine needle. The exact protocol (including dose and any follow-up visits) depends on the patient’s condition.
What side effects do patients usually ask about?
Common patient concerns with intravitreal steroid injections include:
- Increased eye pressure (which can worsen or trigger glaucoma)
- Cataract progression (if the patient is phakic, meaning they still have their natural lens)
- Eye inflammation or irritation
- Risk of infection inside the eye (endophthalmitis), which is rare but serious for any intravitreal injection
Symptoms that warrant urgent call after injection include worsening pain, significant redness, sudden vision drop, or lots of new floaters.
How long do results last, and how many injections might be needed?
Response duration varies by disease and severity. Some patients need repeated injections or additional therapy if swelling returns. Your ophthalmologist typically sets a follow-up schedule (often with vision checks and retinal imaging) to decide whether more injections are needed.
How does Triesence compare with anti-VEGF injections?
For diabetic macular edema and other retinal swelling causes, many patients also receive anti-VEGF drugs (medications that block vascular endothelial growth factor). Triesence is a steroid, so it targets inflammation and can reduce swelling through a different mechanism. Which approach fits best depends on factors like the cause of the edema, prior response to treatments, and risks such as cataract or elevated intraocular pressure.
What risks should be considered before an intravitreal steroid injection?
Key risks to review with the treating eye specialist include:
- Baseline glaucoma or a history of steroid-induced pressure rises
- Lens status (risk of cataract worsening)
- Any current or recent eye infection
- Need for careful follow-up to monitor intraocular pressure and visual function after injection
Where to get dosing and prescribing details
The exact dose (and whether a single injection or a repeated schedule is used) depends on the indication and clinical judgment. For the most accurate instructions for your situation, rely on the prescribing information provided with your treatment and your ophthalmologist’s plan.
If you share what condition you’re treating (for example diabetic macular edema, uveitic macular edema, or retinal vein occlusion) and whether you’re asking about expected duration, side effects, or how it compares to anti-VEGF, I can tailor the answer to that use case.